AstraZeneca Presents Exploratory Sub-analyses From HIMALAYA

LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZ) presented data for IMFINZI combinations from the HIMALAYA and TOPAZ-1 Phase III trials. The company said the HIMALAYA results showed a consistent survival

Related Keywords

London , City Of , United Kingdom , Cristian Massacesi , Astrazeneca , Chief Medical Officer , Oncology Chief Development Officer , Presents , Exploratory , Analyses , Rom , Imalaya , Topaz , Trials ,